AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,246,000 | -47.0% | 699,531 | -35.7% | 0.20% | -45.9% |
| Q1 2022 | $9,906,000 | +29.6% | 1,088,566 | 0.0% | 0.37% | +42.3% |
| Q4 2021 | $7,642,000 | -69.3% | 1,088,566 | -50.1% | 0.26% | -64.5% |
| Q3 2021 | $24,883,000 | -28.8% | 2,182,684 | 0.0% | 0.73% | -33.2% |
| Q2 2021 | $34,945,000 | -5.4% | 2,182,684 | +5.6% | 1.10% | -2.9% |
| Q1 2021 | $36,950,000 | +22.8% | 2,067,684 | -7.2% | 1.13% | +6.5% |
| Q4 2020 | $30,095,000 | +14.8% | 2,227,611 | 0.0% | 1.06% | -12.6% |
| Q3 2020 | $26,219,000 | -21.9% | 2,227,611 | -2.0% | 1.21% | -30.4% |
| Q2 2020 | $33,567,000 | -1.7% | 2,274,220 | -10.0% | 1.74% | -37.9% |
| Q1 2020 | $34,132,000 | -41.5% | 2,528,276 | +4.8% | 2.80% | +0.9% |
| Q4 2019 | $58,333,000 | +65.8% | 2,413,464 | +31.8% | 2.78% | +167.4% |
| Q3 2019 | $35,190,000 | -48.5% | 1,830,924 | -3.3% | 1.04% | -42.8% |
| Q4 2018 | $68,371,000 | -50.8% | 1,893,935 | -16.1% | 1.82% | -10.8% |
| Q3 2018 | $139,007,000 | -24.4% | 2,258,443 | -17.0% | 2.04% | -29.2% |
| Q2 2018 | $183,751,000 | +19.6% | 2,720,218 | -4.0% | 2.88% | -7.9% |
| Q1 2018 | $153,690,000 | -1.3% | 2,833,003 | +8.7% | 3.12% | -15.5% |
| Q4 2017 | $155,781,000 | +32.8% | 2,607,211 | +8.0% | 3.70% | +60.3% |
| Q3 2017 | $117,294,000 | +27.7% | 2,413,461 | +38.1% | 2.30% | -6.9% |
| Q2 2017 | $91,860,000 | +56.6% | 1,748,040 | +35.2% | 2.48% | +68.6% |
| Q1 2017 | $58,643,000 | +7.9% | 1,293,129 | -9.9% | 1.47% | -4.1% |
| Q4 2016 | $54,343,000 | -26.8% | 1,435,755 | -27.0% | 1.53% | -29.5% |
| Q3 2016 | $74,213,000 | +80.1% | 1,966,417 | -16.0% | 2.17% | +74.8% |
| Q2 2016 | $41,213,000 | +42.3% | 2,341,640 | -1.7% | 1.24% | +39.2% |
| Q1 2016 | $28,955,000 | -49.9% | 2,381,135 | +0.3% | 0.89% | -49.2% |
| Q4 2015 | $57,826,000 | +46.9% | 2,374,797 | +7.1% | 1.76% | +58.7% |
| Q3 2015 | $39,351,000 | +20.4% | 2,218,198 | +19.8% | 1.11% | +33.9% |
| Q2 2015 | $32,680,000 | +342.9% | 1,851,564 | +686.4% | 0.83% | +307.4% |
| Q1 2015 | $7,379,000 | – | 235,445 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|